Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?

American Journal of Hypertension

Volumn 18, Issue 12, 2005, Pages 1631-1635

  Mahmud, Azra ^a   Mahgoub, Mohammed ^a   Hall, Mary ^a   Feely, John ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

Aldosterone; Aldosterone to renin ratio; Hypertension; Spironolactone

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE; ALDOSTERONE ANTAGONIST; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BENDROFLUMETHIAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHYLDOPA; POTASSIUM; RENIN; SPIRONOLACTONE;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; FEMALE; GYNECOMASTIA; HUMAN; HYPERKALEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RANDOMIZATION; SYSTOLIC BLOOD PRESSURE;

ALDOSTERONE; ALDOSTERONE ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; BENDROFLUMETHIAZIDE; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RENIN; RENIN-ANGIOTENSIN SYSTEM; SPIRONOLACTONE;

EID: 29144455401     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2005.06.010     Document Type: Article

References (14)

1. S. Hood, J. Cannon, R. Foo, M. Brown Prevalence of primary hyperaldosteronism assessed by aldosterone/renin ratio and spironolactone testing Clin Med 5 2005 55 60
2. P.O. Lim, R.T. Jung, T.M. MacDonald Raised aldosterone-to-renin ratio predicts antihypertensive efficacy of spironolactone a prospective cohort follow-up study Br J Clin Pharmacol 48 1999 756 760
3. J.H. Laragh, J.E. Sealey Relevance of the plasma renin hormonal control system that regulates blood pressure and sodium balance for correctly treating hypertension and for evaluating ALLHAT Am J Hypertens 16 2003 407 415
4. B.M.W. Schmidt, R.E. Schmieder Aldosterone-induced cardiac damage focus on blood pressure independent effects Am J Hypertens 16 2003 80 86
5. A. Mahmud, J. Feely Aldosterone renin ratio, arterial stiffness and the response to aldosterone antagonism in essential hypertension Am J Hypertens 18 2005 50 55
6. B.E. Karlberg, L. Tegler, K. Tolagen, B. Bergman Controlled treatment of primary hypertension with propranolol and spironolactone. A cross-over study with special reference to initial plasma renin activity Am J Cardiol 37 1976 642 649
7. C.S. Brooks, C.A. Johnson, J.M. Kotchen, T.A. Kotchen Diuretic therapies in low renin and normal renin essential hypertension Clin Pharmacol Ther 22 1977 14 20
8. R.K. Ferguson, D.M. Turek, D.R. Rovner Spironolactone and hydrochlorothiazide in normal-renin and low-renin essential hypertension Clin Pharmacol Ther 21 1977 62 69
9. S.B. Solheim, J.A. Sundsfjord, L. Giezendanner The effect of spironolactone (Aldactone) and methyldopa in low and normal renin hypertension Acta Med Scand 197 1975 451 456
10. M.K. Nishizaka, M.A. Zaman, D.A. Calhoun Efficacy of low-dose spironolactone in subjects with resistant hypertension Am J Hypertens 16 2003 925 930
11. P. Mulatero, F. Rabbia, A. Milan, C. Paglieri, F. Morello, L. Chiandussi, F. Veglio Drug effects of aldosterone/plasma renin activity ratio in primary aldosteronism Hypertension 40 2002 897 902
12. B. Schersten, T. Thulin, J. Kuylenstierna, M. Engstrom, B.E. Karlberg, K. Tolagen, S. Nordlander, G. Nilsson Clinical and biochemical effects of spironolactone administered once daily in primary hypertension. Multicenter Sweden study Hypertension 2 1980 672 679
13. J.M. Flack, S. Oparil, H. Pratt, B. Roniker, S. Garthwaite, J.H. Kleiman, Y. Yang, S.L. Krause, D. Workman, E. Saunder Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients J Am Coll Cardiol 41 2003 1148 1155
14. L.M. Prisant, H. Krum, B. Roniker, S.L. Krause, K. Fakouhi, W. He Can renin status predict the antihypertensive efficacy of eplerenone add-on therapy? J Clin Pharmacol 43 2003 1203 1210